Legal & General Group PLC Iovance Biotherapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 243,521 shares of IOVA stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
243,521
Previous 243,521 -0.0%
Holding current value
$1.99 Million
Previous $2.29 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.28 - $11.9 $4,375 - $7,151
601 Added 0.25%
243,521 $2.29 Million
Q2 2024

Aug 14, 2024
BUY
$7.78 - $14.19 $304,789 - $555,907
39,176 Added 19.23%
242,920 $1.95 Million
Q1 2024

May 14, 2024
SELL
$7.59 - $17.47 $186,008 - $428,137
-24,507 Reduced 10.74%
203,744 $3.02 Million
Q4 2023

Feb 15, 2024
BUY
$3.3 - $8.89 $28,449 - $76,640
8,621 Added 3.93%
228,251 $1.86 Million
Q3 2023

Nov 14, 2023
BUY
$4.44 - $8.79 $211,579 - $418,869
47,653 Added 27.71%
219,630 $999,000
Q2 2023

Aug 14, 2023
BUY
$5.36 - $9.06 $270,669 - $457,511
50,498 Added 41.57%
171,977 $1.21 Million
Q1 2023

May 15, 2023
SELL
$5.53 - $8.22 $40,910 - $60,811
-7,398 Reduced 5.74%
121,479 $742,000
Q4 2022

Feb 14, 2023
BUY
$5.62 - $10.0 $35,833 - $63,760
6,376 Added 5.2%
128,877 $823,000
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $34,698 - $47,733
-3,641 Reduced 2.89%
122,501 $1.17 Million
Q2 2022

Aug 22, 2022
SELL
$6.38 - $18.33 $13,079 - $37,576
-2,050 Reduced 1.6%
126,142 $1.39 Million
Q1 2022

May 16, 2022
BUY
$12.38 - $19.1 $16,143 - $24,906
1,304 Added 1.03%
128,192 $2.13 Million
Q4 2021

Feb 14, 2022
BUY
$16.55 - $27.63 $270,211 - $451,115
16,327 Added 14.77%
126,888 $2.42 Million
Q3 2021

Nov 15, 2021
BUY
$20.35 - $26.63 $512,413 - $670,543
25,180 Added 29.49%
110,561 $2.73 Million
Q2 2021

Aug 12, 2021
SELL
$16.33 - $33.07 $140,291 - $284,104
-8,591 Reduced 9.14%
85,381 $2.22 Million
Q1 2021

May 17, 2021
BUY
$28.67 - $52.59 $20,183 - $37,023
704 Added 0.75%
93,972 $2.98 Million
Q4 2020

Feb 12, 2021
SELL
$28.04 - $50.26 $521,095 - $934,031
-18,584 Reduced 16.61%
93,268 $4.33 Million
Q3 2020

Nov 13, 2020
SELL
$27.75 - $36.3 $8,741 - $11,434
-315 Reduced 0.28%
111,852 $3.68 Million
Q2 2020

Aug 14, 2020
BUY
$27.21 - $41.0 $854,938 - $1.29 Million
31,420 Added 38.91%
112,167 $3.08 Million
Q1 2020

May 14, 2020
BUY
$19.54 - $38.85 $240,185 - $477,544
12,292 Added 17.96%
80,747 $2.42 Million
Q4 2019

Feb 13, 2020
BUY
$17.95 - $29.41 $90,791 - $148,755
5,058 Added 7.98%
68,455 $1.9 Million
Q3 2019

Nov 13, 2019
BUY
$17.99 - $26.0 $729,512 - $1.05 Million
40,551 Added 177.5%
63,397 $1.15 Million
Q2 2019

Aug 14, 2019
BUY
$9.78 - $24.52 $34,073 - $85,427
3,484 Added 17.99%
22,846 $561,000
Q1 2019

May 15, 2019
BUY
$8.41 - $11.26 $4,196 - $5,618
499 Added 2.65%
19,362 $184,000
Q4 2018

Feb 15, 2019
BUY
$7.51 - $11.93 $43,512 - $69,122
5,794 Added 44.33%
18,863 $166,000
Q2 2018

Aug 10, 2018
SELL
$12.45 - $16.95 $10,159 - $13,831
-816 Reduced 5.88%
13,069 $167,000
Q1 2018

May 17, 2018
SELL
$8.1 - $19.5 $9,436 - $22,717
-1,165 Reduced 7.74%
13,885 $235,000
Q4 2017

Feb 13, 2018
BUY
$6.65 - $9.25 $100,082 - $139,212
15,050
15,050 $122,000

Others Institutions Holding IOVA

# of Institutions
315
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.29B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email